News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
682,324 Results
Type
Article (66970)
Company Profile (143)
Press Release (615197)
Multimedia
Podcasts (91)
Webinars (20)
Section
Business (180454)
Career Advice (2809)
Deals (32432)
Drug Delivery (115)
Drug Development (79764)
Employer Resources (163)
FDA (16887)
Job Trends (14448)
News (318303)
Policy (31819)
Tag
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (2907)
Academic (1)
Accelerated approval (34)
Adcomms (31)
Allergies (144)
Alliances (49903)
ALS (176)
Alzheimer's disease (1742)
Antibody-drug conjugate (ADC) (305)
Approvals (17106)
Artificial intelligence (534)
Autoimmune disease (157)
Automation (35)
Bankruptcy (340)
Best Places to Work (11133)
BIOSECURE Act (22)
Biosimilars (182)
Biotechnology (89)
Bladder cancer (151)
Brain cancer (62)
Breast cancer (639)
Cancer (4849)
Cardiovascular disease (408)
Career advice (2378)
Career pathing (41)
CAR-T (285)
CDC (49)
Celiac Disease (1)
Cell therapy (765)
Cervical cancer (36)
Clinical research (67648)
Collaboration (1762)
Company closure (3)
Compensation (586)
Complete response letters (70)
COVID-19 (2800)
CRISPR (90)
C-suite (853)
Cystic fibrosis (150)
Data (6120)
Decentralized trials (2)
Denatured (27)
Depression (142)
Diabetes (490)
Diagnostics (6443)
Digital health (42)
Diversity (10)
Diversity, equity & inclusion (41)
Drug discovery (270)
Drug pricing (191)
Drug shortages (25)
Duchenne muscular dystrophy (234)
Earnings (69022)
Editorial (63)
Employer branding (23)
Employer resources (149)
Events (90768)
Executive appointments (989)
FDA (20041)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1486)
Gene editing (195)
Generative AI (51)
Gene therapy (616)
GLP-1 (970)
Government (4460)
Grass and pollen (7)
Guidances (383)
Healthcare (17934)
HIV (58)
Huntington's disease (41)
IgA nephropathy (82)
Immunology and inflammation (239)
Immuno-oncology (59)
Indications (108)
Infectious disease (3070)
Inflammatory bowel disease (188)
Inflation Reduction Act (11)
Influenza (117)
Intellectual property (251)
Interviews (528)
IPO (14825)
IRA (48)
Job creations (3650)
Job search strategy (1957)
JPM (64)
Kidney cancer (17)
Labor market (74)
Layoffs (527)
Leadership (37)
Legal (7035)
Liver cancer (95)
Longevity (14)
Lung cancer (647)
Lymphoma (373)
Machine learning (44)
Management (55)
Manufacturing (768)
MASH (164)
Medical device (12506)
Medtech (12553)
Mergers & acquisitions (18630)
Metabolic disorders (1243)
Multiple sclerosis (168)
NASH (19)
Neurodegenerative disease (335)
Neuropsychiatric disorders (85)
Neuroscience (3002)
Neurotech (1)
NextGen: Class of 2026 (6231)
Non-profit (4745)
Now hiring (53)
Obesity (572)
Opinion (307)
Ovarian cancer (165)
Pain (203)
Pancreatic cancer (227)
Parkinson's disease (288)
Partnered (37)
Patents (500)
Patient recruitment (496)
Peanut (58)
People (55484)
Pharmaceutical (40)
Pharmacy benefit managers (27)
Phase 1 (20958)
Phase 2 (29612)
Phase 3 (22288)
Pipeline (5214)
Policy (286)
Postmarket research (2675)
Preclinical (9420)
Press Release (67)
Prostate cancer (243)
Psychedelics (51)
Radiopharmaceuticals (277)
Rare diseases (874)
Real estate (5693)
Recruiting (72)
Regulatory (24831)
Reports (37)
Research institute (2700)
Resumes & cover letters (448)
Rett syndrome (27)
RNA editing (14)
RSV (76)
Schizophrenia (152)
Series A (236)
Series B (183)
Service/supplier (11)
Sickle cell disease (95)
Special edition (24)
Spinal muscular atrophy (172)
Sponsored (45)
Startups (3487)
State (2)
Stomach cancer (13)
Supply chain (101)
Tariffs (79)
The Weekly (63)
Vaccines (1062)
Venture capital (90)
Weight loss (369)
Women's health (85)
Worklife (20)
Date
Today (143)
Last 7 days (524)
Last 30 days (1949)
Last 365 days (28447)
2026 (3102)
2025 (28742)
2024 (33155)
2023 (37552)
2022 (48311)
2021 (52432)
2020 (51173)
2019 (44647)
2018 (34034)
2017 (31713)
2016 (30975)
2015 (36113)
2014 (28846)
2013 (25572)
2012 (26436)
2011 (27097)
2010 (25878)
Location
Africa (946)
Alabama (88)
Alaska (6)
Arizona (245)
Arkansas (13)
Asia (42310)
Australia (7461)
California (10007)
Canada (3146)
China (1117)
Colorado (451)
Connecticut (461)
Delaware (294)
Europe (95933)
Florida (1567)
Georgia (327)
Hawaii (3)
Idaho (55)
Illinois (839)
India (67)
Indiana (481)
Iowa (21)
Japan (422)
Kansas (119)
Kentucky (33)
Louisiana (26)
Maine (79)
Maryland (1261)
Massachusetts (7204)
Michigan (309)
Minnesota (541)
Mississippi (6)
Missouri (127)
Montana (36)
Nebraska (27)
Nevada (117)
New Hampshire (73)
New Jersey (2868)
New Mexico (33)
New York (2834)
North Carolina (1394)
North Dakota (9)
Northern California (4795)
Ohio (321)
Oklahoma (21)
Oregon (40)
Pennsylvania (2042)
Puerto Rico (24)
Rhode Island (40)
South America (1223)
South Carolina (67)
South Dakota (1)
Southern California (3970)
Tennessee (163)
Texas (1660)
United States (36560)
Utah (316)
Vermont (1)
Virginia (256)
Washington D.C. (76)
Washington State (861)
West Virginia (3)
Wisconsin (106)
Wyoming (2)
682,324 Results for "novartis institutes for biomedical research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
February 9, 2026
·
6 min read
Press Releases
Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
December 2, 2025
·
11 min read
Pipeline
Novartis Cuts 6 Early Cancer Candidates, Adds 2 to Refine Oncology Strategy
Despite the Phase 1 cull, CEO Vas Narasimhan on Wednesday maintained that Novartis continues to invest in its early-stage pipeline, looking for deals in the “sub-$2-billion range.”
February 5, 2026
·
2 min read
·
Tristan Manalac
Earnings
Novartis Sticks With M&A Strategy of Building Early Pipeline, Searching for Near-Launches
Novartis will still be on the lookout for early-stage deals under $2 billion, and later-stage agreements around a product that could reach the market within five years, CEO Vas Narasimhan said Wednesday.
February 4, 2026
·
2 min read
·
Tristan Manalac
Press Releases
IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions
February 10, 2026
·
5 min read
Press Releases
Feinstein Institutes’ Dr. Stephanie Fitzpatrick elected Fellow of the Academy of Behavior Medicine Research
February 5, 2026
·
3 min read
Press Releases
Federal Funding Bill Commits $3 Million to Versiti Blood Research Institute Expansion
February 5, 2026
·
2 min read
Alzheimer’s disease
Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro
The deal will see Novartis gain global rights over SciNeuro’s potentially disease-modifying anti-amyloid antibody, which leverages the latter’s proprietary shuttle platform to allow delivery into the brain.
January 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Israel Cancer Research Fund and Cancer Research Institute Announce Co-Funding of Grant to Address Immunotherapy Resistance in Melanoma
January 23, 2026
·
3 min read
Press Releases
HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services
January 21, 2026
·
3 min read
1 of 68,233
Next
